5.92

5.34% 0.30

After Hours: 5.92

Maravai Lifesciences Holdings Inc (MRVI)

Overview News Price History Option Chain Financials Why MRVI Down? Discussions Forecast

Maravai Lifesciences Holdings Inc stock is traded at $5.92, with a volume of 2.32M. It is up +5.34% in the last 24 hours and down -15.67% over the past month. Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Previous Close:

$5.62

Open:

$5.62

24h Volume:

2.32M

Relative Volume:

1.31

Market Cap:

$843.97M

Revenue:

$288.95M

Net Income/Loss:

$-119.03M

P/E Ratio:

10.40

EPS:

0.5695

Net Cash Flow:

$60.67M

1W Performance:

+22.82%

1M Performance:

-15.67%

6M Performance:

-45.44%

1Y Performance:

+15.62%

1-Day Range:

$5.61

$6.005

1-Week Range:

$4.745

$6.005

52-Week Range:

$4.275

$11.55

Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile

Name

Maravai Lifesciences Holdings Inc

Sector

Healthcare (1200)

Industry

Biotechnology (682)

Phone

(858) 546-0004

Address

10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO

Employee

580

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

MRVI's Discussions on Twitter

Compare MRVI with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MRVI Maravai Lifesciences Holdings Inc	5.92	843.97M	288.95M	-119.03M	60.67M	0.5695
VRTX Vertex Pharmaceuticals Inc	464.56	119.70B	10.63B	-479.80M	-1.35B	13.33
REGN Regeneron Pharmaceuticals Inc	754.87	82.75B	13.85B	4.65B	3.32B	35.06
ARGX Argen X Se Adr	614.59	36.73B	1.86B	-40.29M	-1.28B	-4.16
ALNY Alnylam Pharmaceuticals Inc	253.74	32.53B	2.09B	-332.26M	16.06M	-4.14
BNTX Biontech Se Adr	120.72	28.50B	3.30B	-501.07M	1.03B	11.54

Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-14-24	Initiated	Wolfe Research	Peer Perform
Nov-08-24	Downgrade	William Blair	Outperform → Mkt Perform
Aug-28-24	Initiated	Wells Fargo	Overweight
Aug-13-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Apr-10-24	Initiated	Craig Hallum	Buy
Dec-12-23	Upgrade	BofA Securities	Neutral → Buy
Aug-08-23	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
May-23-23	Downgrade	Credit Suisse	Outperform → Neutral
May-09-23	Downgrade	Goldman	Buy → Neutral
Jan-05-23	Downgrade	UBS	Buy → Neutral
Dec-14-22	Initiated	Deutsche Bank	Buy
Dec-07-22	Initiated	RBC Capital Mkts	Outperform
Nov-03-22	Downgrade	BofA Securities	Buy → Neutral
Aug-25-22	Initiated	Credit Suisse	Outperform
Aug-05-21	Resumed	Credit Suisse	Outperform
Dec-16-20	Initiated	KeyBanc Capital Markets	Overweight
Dec-15-20	Initiated	BofA Securities	Buy
Dec-15-20	Initiated	Credit Suisse	Outperform
Dec-15-20	Initiated	Goldman	Buy
Dec-15-20	Initiated	Jefferies	Buy
Dec-15-20	Initiated	Robert W. Baird	Outperform
Dec-15-20	Initiated	Stifel	Buy
Dec-15-20	Initiated	William Blair	Outperform
Dec-14-20	Initiated	UBS	Buy

View All

Maravai Lifesciences Holdings Inc Stock (MRVI) Latest News

Nov 26, 2024

Massachusetts Financial Services Co. MA Sells 948,778 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat

Nov 26, 2024

Nov 25, 2024

Maravai LifeSciences: Still Struggling To Find Its Footing (NASDAQ:MRVI) - Seeking Alpha

Nov 25, 2024

Nov 24, 2024

Maravai LifeSciences Holdings (MEX:MRVI) Payments of Debt : MXN-108 Mil (TTM As of Sep. 2024) - GuruFocus.com

Nov 24, 2024

Nov 23, 2024

Jennison Associates LLC Has $24.77 Million Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat

Nov 23, 2024

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Shares Sold by Principal Financial Group Inc. - MarketBeat

Nov 23, 2024

Nov 22, 2024

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Nov 22, 2024

Nov 20, 2024

Wolfe Research Initiates Coverage of Maravai LifeSciences Holdings (MRVI) with Peer Perform Recommendation - MSN

Nov 20, 2024

Nov 18, 2024

What Do Analysts Think About Maravai LifeSciences Holdings Inc’s (NASDAQ:MRVI) Future? - Stocks Register

Nov 18, 2024

Royce & Associates LP Increases Stock Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - MarketBeat

Nov 18, 2024

Nov 16, 2024

Maravai LifeSciences (NASDAQ:MRVI) Trading Down 7.5%Here's What Happened - MarketBeat

Nov 16, 2024

Maravai LifeSciences shares initiated with Peerperform on positive aspects - Investing.com India

Nov 15, 2024

Maravai lifesci director John DeFord acquires $100,625 in stock - Investing.com

Nov 15, 2024

Nov 14, 2024

Insider Buying: Director John Deford Acquires Shares of Maravai LifeSciences Holdings Inc (MRVI) - GuruFocus.com

Nov 14, 2024

Maravai LifeSciences shares initiated with Peerperform on positive aspects By Investing.com - Investing.com Canada

Nov 14, 2024

Maravai LifeSciences (NASDAQ:MRVI) Now Covered by Wolfe Research - MarketBeat

Nov 14, 2024

Maravai LifeSciences Target of Unusually Large Options Trading (NASDAQ:MRVI) - MarketBeat

Nov 14, 2024

Nov 13, 2024

12 West Capital Management LP's Strategic Acquisition in Maravai LifeSciences Holdings Inc - GuruFocus.com

Nov 13, 2024

Maravai LifeSciences (NASDAQ:MRVI) Shares Gap Up Following Insider Buying Activity - MarketBeat

Nov 13, 2024

Nov 12, 2024

Maravai LifeSciences Announces November 2024 Investor Conference Schedule - GlobeNewswire

Nov 12, 2024

Earnings call: Maravai LifeSciences reports mixed Q3 results, eyes growth - Investing.com India

Nov 12, 2024

Maravai LifeSciences (NASDAQ:MRVI) Price Target Cut to $13.00 by Analysts at Royal Bank of Canada - Defense World

Nov 12, 2024

Nov 11, 2024

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 11, 2024

Slammed 37% Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Screens Well Here But There Might Be A Catch - Simply Wall St

Nov 11, 2024

Nov 10, 2024

Maravai Lifesciences price target lowered to $7 from $10 at Morgan Stanley - MSN

Nov 10, 2024

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Just Reported Earnings, And Analysts Cut Their Target Price - Yahoo Finance

Nov 10, 2024

Nov 09, 2024

Maravai LifeSciences (NASDAQ:MRVI) Shares Gap Down on Analyst Downgrade - Defense World

Nov 09, 2024

Maravai Lifesciences price target lowered to $9 from $10 at Baird - Yahoo Finance

Nov 09, 2024

Nov 08, 2024

Health Care Up on Another Round of Mixed Earnings -- Health Care Roundup - Marketscreener.com

Nov 08, 2024

Royal Bank of Canada Has Lowered Expectations for Maravai LifeSciences (NASDAQ:MRVI) Stock Price - MarketBeat

Nov 08, 2024

Maravai LifeSciences stock plunges 39% amid lowered revenue forecast - MSN

Nov 08, 2024

Maravai LifeSciences stock plunges 39% amid lowered revenue forecast (NASDAQ:MRVI) - Seeking Alpha

Nov 08, 2024

U.S. Stock market: Evolent Health(-43.35%), Maravai LifeSciences(-38.65%), and Chanson International(-38.04%) in midday trading - Business Upturn

Nov 08, 2024

Maravai LifeSciences (NASDAQ:MRVI) Shares Gap Down Following Analyst Downgrade - MarketBeat

Nov 08, 2024

U.S. Stock market: Evolent Health (-41.07%), Maravai LifeSciences(-34.44%), Revance Therapeutics(-32.01%) as top losers during early trading - Business Upturn

Nov 08, 2024

Maravai LifeSciences (NASDAQ:MRVI) Given New $9.00 Price Target at Robert W. Baird - MarketBeat

Nov 08, 2024

Maravai LifeSciences' (MRVI) Market Perform Rating Reaffirmed at William Blair - MarketBeat

Nov 08, 2024

Decoding 5 Analyst Evaluations For Maravai LifeSciences - Benzinga

Nov 08, 2024

Maravai LifeSciences (MRVI) Q3 2024 Earnings Call Transcript - AOL

Nov 08, 2024